[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100653587":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":17,"armGroups":13,"interventions":13,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":37,"collaborators":13,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":13,"enrollmentInfo":49,"targetDuration":52,"studyType":53,"phases":13,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":62,"whyStopped":13,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Medical University of Warsaw","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Occurrence of at least one infectious complication within 30 days after liver transplantation","Binary outcome (yes\u002Fno), including: pneumonia (clinical, radiological, and microbiological criteria), urinary tract infection (clinical symptoms + positive urine culture), surgical site infection per CDC criteria, sepsis\u002Fseptic shock per Sepsis-3 criteria.","30 days",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"COHORT","PROSPECTIVE","patients undergoing liver transplantation at the 2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw.",[19],{"name":20,"role":21,"phone":22,"phoneExt":13,"email":23},"Paula Dudek, MD","CONTACT","+225992002","paula.dudek@wum.edu.pl",[25],{"facility":5,"status":13,"city":26,"state":13,"zip":13,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Warsaw","Poland","PL",{"type":30,"coordinates":31},"Point",[32,33],21.01178,52.22977,{"lat":33,"lon":32},[36],{"name":20,"role":21,"phone":22,"phoneExt":13,"email":23},{"type":38,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100653587","intraoperative-glycemic-variability-and-infectious-complications-after-liver-transplantation-100653587",false,"NCT07786857","Intraoperative Glycemic Variability and Infectious Complications After Liver Transplantation","Intraoperative Glycemic Variability and the Risk of Infectious Complications After Elective Liver Transplantation: A Prospective Cohort Study","SUGAR-LT","Inclusion Criteria:\n\n* Age over 18 years\n* Elective orthotopic liver transplantation\n\nExclusion Criteria:\n\n* Liver retransplantation\n* multi-organ transplantation\n* Urgent\u002Femergency transplantation\n* Active infection under antibiotic treatment at the time of surgery\n* Preoperative systemic inflammatory response syndrome (SIRS)\n* Incomplete intraoperative glycemic data\n* Pregnancy\n* Participation in another interventional study that could affect glycemic control or infection risk","ALL","18 Years",{"count":50,"type":51},240,"ESTIMATED","30 Days","OBSERVATIONAL","This study aims to evaluate whether intraoperative glycemic variability (GV) is independently associated with the risk of infectious complications within 30 days after elective liver transplantation. This is an observational study with no intervention beyond standard perioperative care. Glycemic and clinical outcome data will be obtained from routinely collected medical records of patients undergoing liver transplantation at the 2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw.",[56],"Liver Transplantation (LT)",[58,59,60,61],"liver transplantation","glycemic variability","postoperative infections","surgical site infection","NOT_YET_RECRUITING","2026-08-24",{"date":65,"type":66},"2026-08-26","ACTUAL",{"date":68,"type":51},"2026-08-01",{"date":70,"type":51},"2027-07-30",{"name":5,"class":6},1]